z-logo
Premium
Oral direct‐acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus–related cirrhosis
Author(s) -
Kwo Paul Y.,
Tector A. Joseph
Publication year - 2013
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.23662
Subject(s) - medicine , gastroenterology , cirrhosis , liver transplantation , liver disease , ribavirin , ascites , hepatitis c virus , sofosbuvir , hepatitis c , hepatic encephalopathy , model for end stage liver disease , transplantation , immunology , virus

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom